20 件中 1 - 20 件目
英語 :Kosaka A, Yajima Y, Yasuda S, Komatsuda H, Nagato T, Oikawa K, Kobayashi H, Ohkuri T. , Celecoxib promotes the efficacy of STING-targeted therapy by increasing antitumor CD8+ T-cell functions via modulating glucose metabolism of CD11b+Ly6G+ cells , International Journal of Cancer, 152 (8) (1685 - 1697) , 2023
英語 :Nagato T, Komatsuda H, Hayashi R, Takahara M, Kishibe K, Yasuda S, Yajima Y, Kosaka A, Ohkuri T, Oikawa K, Harabuchi S, Kono M, Yamaki H, Wakisaka R, Hirata-Nozaki Y, Ohara K, Kumai T, Katada A, Hayashi T, Harabuchi Y, Kobayashi H. , Expression of soluble CD27 in extranodal natural killer/T-cell lymphoma, nasal type: potential as a biomarker for diagnosis and CD27/CD70-targeted therapy , Cancer Immunology, Immunotherapy , 2023
英語 :Komatsuda H, Wakisaka R, Kono M, Kumai T, Hayashi R, Yamaki H, Sato R, Nagato T, Ohkuri T, Kosaka A, Ohara K, Takahara M, Katada A, Kobayashi H. , Mitogen-activated protein kinase inhibition augments the T cell response against HOXB7-expressing tumor through human leukocyte antigen upregulation , Cancer Science, 114 (2) (399 - 409) , 2023
英語 :矢島優己他 , A tumor metastasis-associated molecule TWIST1 is a favorable target for cancer immunotherapy due to its immunogenicity , Cancer Science, 113 (8) (2526 - 2535) , 2022 , (IF:6.518)
英語 :Kono M, Komatsuda H, Yamaki H, Kumai T, Hayashi R, Wakisaka R, Nagato T, Ohkuri T, Kosaka A, Ohara K, Kishibe K, Takahara M, Katada A, Hayashi T, Kobayashi H, Harabuchi Y. , Immunomodulation via FGFR inhibition augments FGFR1 targeting T-cell based antitumor immunotherapy for head and neck squamous cell carcinoma. , Oncoimmunology , 2022 , (IF:8.11)
英語 :Michihisa Kono, Takumi Kumai, Ryusuke Hayashi, Hidekiyo Yamaki, Hiroki Komatsuda, Risa Wakisaka, Toshihiro Nagato, Takayuki Ohkuri, Akemi Kosaka, Kenzo Ohara, Kan Kishibe, Miki Takahara, Akihiro Katada, Tatsuya Hayashi, Esteban Celis, Hiroya Kobayashi, Yasuaki Harabuchi , Interruption of MDM2 signaling augments MDM2-targeted T cell-based antitumor immunotherapy through antigen-presenting machinery , Cancer Immunology Immunotherapy, 70 (12) (3421 - 3434) , 2021 , (IF:6.968)
英語 :Kosaka A, Ishibashi Kei, Ohkuri T 他 , CD47 blockade enhances the efficacy of intratumoral STING-targeting therapy by activating phagocytes , Journal of Experimental Medicine , 2021 , (IF:14.307)
英語 :Yokouchi H. 他 , Prognostic significance of OX40 + lymphocytes in tumor stroma of surgically resected small-cell lung cancer , Oncoimmuology , 2021 , (IF:8.110)
英語 :Marino Nagata, Akemi Kosaka, Yuki Yajima, Syunsuke Yasuda, Mizuho Ohara, Kenzo Ohara, Shohei Harabuchi, Ryusuke Hayashi, Hiroshi Funakoshi, Jun Ueda, Takumi Kumai, Toshihiro Nagato, Kensuke Oikawa, Yasuaki Harabuchi, Celis Esteban, Takayuki Ohkuri, Hiroya Kobayashi , A critical role of STING-triggered tumor-migrating neutrophils for anti-tumor effect of intratumoral cGAMP treatment , Cancer Immunology Immunotherapy , 2021 , (IF:6.968)
英語 :Akemi Kosaka, Yuki Yajima, Mayumi Hatayama, Katsuya Ikuta, Takaaki Sasaki, Noriko Hirai, Syunsuke Yasuda, Marino Nagata, Ryusuke Hayashi, Shohei Harabuchi, Kenzo Ohara, Mizuho Ohara, Takumi Kumai, Kei Ishibashi, Yui Hirata-Nozaki, Toshihiro Nagato, Kensuke Oikawa, Yasuaki Harabuchi, Esteban Celis, Toshikatsu Okumura, Yoshinobu Ohsaki, Hiroya Kobayashi, Takayuki Ohkuri , A stealth antigen SPESP1, which is epigenetically silenced in tumors, is a suitable target for cancer immunotherapy , Cancer Science, 112 (7) (2705 - 2713) , 2021 , (IF:6.716)
英語 :Takayuki Ohkuri, Akemi Kosaka, Maki Ikeura, Andres M Salazar, Hideho Okada , IFN-γ- and IL-17-producing CD8 + T (Tc17-1) cells in combination with poly-ICLC and peptide vaccine exhibit antiglioma activity , Journal for ImmunoTherapy of Cancer, 9 (6) , 2021 , (IF:13.751)
英語 :Ryusuke Hayashi, Toshihiro Nagato, Takumi Kuma, Kenzo Ohara, Mizuho Ohara, Takayuki Ohkuri, Yui Hirata-Nozaki, Shohei Harabuchi, Akemi Kosaka, Marino Nagata, Yuki Yajima, Syunsuke Yasuda, Kensuke Oikawa, Michihisa Kono, Kan Kishibe, Miki Takahara, Akihiro Katada, Tatsuya Hayashi, Esteban Celis, Yasuaki Harabuchi, Hiroya Kobayashi , Expression of placenta-specific 1 and its potential for eliciting anti-tumor helper T-cell responses in head and neck squamous cell carcinoma , Oncoimmunology, 10 (1) , 2020 , (IF:8.110)
英語 :Mizuho Ohara, Kenzo Ohara, Takumi Kumai, Takayuki Ohkuri, Toshihiro Nagato, Yui Hirata-Nozaki, Akemi Kosaka, Marino Nagata, Ryusuke Hayashi, Shohei Harabuchi, Yuki Yajima, Kensuke Oikawa, Yasuaki Harabuchi , Yasuo Sumi, Hiroyuki Furukawa, Hiroya Kobayashi , Phosphorylated Vimentin as an Immunotherapeutic Target Against Metastatic Colorectal Cancer , CANCER IMMUNOLOGY IMMUNOTHERAPY , 2020 , (IF:4.900)
英語 :Shohei Harabuchi, Akemi Kosaka, Yuki Yajima, Marino Nagata, Ryusuke Hayashi, Takumi Kumai, Kenzo Ohara, Toshihiro Nagato, Kensuke Oikawa, Mizuho Ohara, Yasuaki Harabuchi, Takayuki Ohkuri, Hiroya Kobayashi , Intratumoral STING Activations Overcome Negative Impact of Cisplatin on Antitumor Immunity by Inflaming Tumor Microenvironment in Squamous Cell Carcinoma , Biochemical and Biophysical Research Communications, 522 (2) (408 - 414) , 2020 , (IF:2.705)
英語 :Yui Hirata-Nozaki, Takayuki Ohkuri, Kenzo Ohara, Takumi Kumai, Marino Nagata, Shohei Harabuchi, Akemi Kosaka, Toshihiro Nagato, Kei Ishibashi, Kensuke Oikawa, Naoko Aoki, Mizuho Ohara, Yasuaki Harabuch, Yuji Uno, Hidehiro Takei, Esteban Celis, Hiroya Kobayashi , PD-L1-specific Helper T-cells Exhibit Effective Antitumor Responses: New Strategy of Cancer Immunotherapy Targeting PD-L1 in Head and Neck Squamous Cell Carcinoma , Journal of Translational Medicine, 17 (1) (207 - ) , 2019 , (IF:4.098)
英語 :Nagato T, Ueda S, Takahara M, Kishibe K, Komabayashi Y, Kumai T, Ohara K, Hirata-Nozaki Y, Harabuchi S, Hayashi R, Ohkuri T, Bernasconi M, Nadal D, Kobayashi H, Harabuchi Y. , Cyclin-dependent kinase 1 and surviving as potential therapeutic targets against nasal natural killer/T-cell lymphoma. , Laboratory Investigation, 99 (5) (612 - 624) , 2019 , (IF:4.254)
英語 :Ohara K, Ohkuri T**, Nagato T, Hirata-Nozaki Y, Ishibashi K, Kosaka A, Nagata M, Harabuchi S, Ohara M, Oikawa K, Aoki N, Harabuchi Y, Celis E, Kobayashi H. , Targeting phosphorylated p53 to elicit tumor-reactive T helper responses against head and neck squamous cell carcinoma. , Oncoimmunology, 7 (9) , 2018 , (IF:5.503)
英語 :Takayuki Ohkuri, Akemi Kosaka, Toshihiro Nagato, Hiroya Kobayashi , Effects of STING stimulation on macrophages: STING agonists polarize into "classically" or "alternatively" activated macrophages? , Human Vaccine & Immunotherapeutics, 14 (2) (285 - 287) , 2018 , (IF:2.157)
英語 :Uehara J, Ohkuri T, Kosaka A, Ishibashi K, Hirata Y, Ohara K, Nagato T, Oikawa K, Aoki N, Harabuchi Y, Ishida-Yamamoto A, Kobayashi H , Intratumoral injection of IFN-β induces chemokine production in melanoma and augments the therapeutic efficacy of anti-PD-L1 mAb. , Biochemical and Biophysical Research Communications, 490 (2) (521 - 527) , 2017
英語 :Ohkuri T, Kosaka A, Ishibashi K, Kumai T, Hirata Y, Ohara K, Nagato T, Oikawa K, Aoki N, Harabuchi Y, Celis E, Kobayashi H. , Intratumoral administration of cGAMP transiently accumulates potent macrophages for anti-tumor immunity at a mouse tumor site. , Cancer Immunology, Immunotherapy, 66 (6) (705 - 716) , 2017 , (IF:4.846)
Page: [<<PREV] [1] [NEXT>>]
Copyright (C) 2012~ Asahikawa Medical University, All Rights Reserved.